-
Mashup Score: 0
Some analysts are questioning whether Amgen was fully forthcoming about a pricey lung cancer drug that is supposed to generate key revenue growth.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 3Quality and transparency of evidence for implantable cardiovascular medical devices assessed by the CORE-MD Consortium - 8 month(s) ago
AbstractBackground and Aims. The European Union Medical Device Regulation 2017/745 challenges key stakeholders to follow transparent and rigorous approaches to
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#Quality and #transparency of evidence for implantable #cardiovascular medical devices assessed by the CORE-MD Consortium 👉 https://t.co/k445WMhQMQ #ESCCongress #EHJ @ehj_ed @rladeiraslopes https://t.co/5z840dfALl
-
-
Mashup Score: 0South Africa ordered to disclose contracts with Pfizer, J&J, and other Covid-19 vaccine suppliers - 8 month(s) ago
A South African court ruled the government must disclose contracts signed with pharmaceutical companies for Covid vaccines, a victory for advocates who alleged authorities may have overpaid for the shots.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet-
South Africa ordered to disclose contracts with Pfizer, J&J, and other Covid-19 vaccine suppliers.. read the court ruling here.. https://t.co/cgexo0ydsl #pharma #COVID19 #vaccines #transparency #SouthAfrica $PFE $JNJ
-
-
Mashup Score: 0Generic group sues Minnesota over a drug pricing transparency law it calls an 'unconstitutional overreach' - 10 month(s) ago
The generic trade group argued the “draconian regulations” come at a time when the industry is “already undergoing severe financial strain.”
Source: STATCategories: General Medicine News, Latest HeadlinesTweet-
Generic group sues Minnesota over a drug pricing transparency law it calls an “unconstitutional overreach”.. you can read the lawsuit here.. https://t.co/Y1jKT0KEJ6 #pharma #generics #transparency #constitutional #Minnesota
-
-
Mashup Score: 0Healthcare must set guardrails around AI for transparency and safety - 11 month(s) ago
Industry-defined limitations can help ensure an accelerated path to adoption by protecting providers from algorithm failures that could cause counter-evolutionary overreactions to artificial intelligence usage, says one CTO.
Source: Healthcare IT NewsCategories: Healthcare Professionals, Latest HeadlinesTweet-
#Healthcare must set guardrails around #AI for #transparency & safety - Industry-defined limitations can help ensure accelerated path to adoption by protecting providers from algorithm failures that could cause counter-evolutionary overreaction to AI usage https://t.co/9AFR67bJ4B
-
-
Mashup Score: 0Most of Canada's public research universities get bad grades for ensuring access to drugs they discover - 12 month(s) ago
“It’s critical the schools steward biomedical research in a way that preserves access and addresses the world’s greatest needs,” said Universities Allied for Essential Medicines.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet-
Most of Canada’s public research universities get bad grades for ensuring access to drugs they discover.. https://t.co/GCFIGkTqyU #pharma #Canada #transparency #patents
-
-
Mashup Score: 2
In this episode our host, Denise Silber, is joined by David Kusin, Harvard MBA, a man whose passions for art and capital markets, led him to found Kusin & Company, the first ever established art economics firm. Together they discuss how his company is bringing liquidity and transpa
Source: HARVARD ALUMNI ENTREPRENEURSCategories: Healthcare Professionals, Latest HeadlinesTweet-
‼️Don't miss my new podcast episode for #Harvard #alumni #entrepreneurs: My guest #hbs #mba David Kusin @sasha_caius combined his #art & #finance passions to create a unique #DataAnalytics platform & bring #transparency to #art #prices 🏆https://t.co/jmZLEfC0fL https://t.co/cxdPAwwdxX
-
-
Mashup Score: 0Pharmalittle: GSK will buy Bellus Health for $2 billion; FDA inspectors are leaving faster than they can be replaced - 1 year(s) ago
GSK plans to purchase Bellus Health for $2 billion, adding a promising chronic cough drug to its pipeline.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet-
Pharmalot.. Pharmalittle.. Good Morning: GSK will buy Bellus Health for $2 billion; FDA inspectors are leaving faster than they can be replaced & More news.. https://t.co/pc69NZdk7S #pharma #FDA #COVID19 #vaccines #clinicaltrials #transparency $GSK $NVS $SNY $BLU $PFE $AZN
-
-
Mashup Score: 0Most large U.S. funders of clinical research have poor transparency policies, analysis finds - 1 year(s) ago
A new analysis finds that only 37% of the 14 largest public and philanthropic organizations that fund clinical research in the U.S. have implemented the best disclosure practices recommended by the WHO.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet-
Most large U.S. funders of clinical research have poor transparency policies.. https://t.co/ZcPcMyECXM #pharma #transparency #clinicaltrials #Gates #NIH
-
-
Mashup Score: 5How many? One-third of late-stage trials testing multiple sclerosis drugs were never published - 1 year(s) ago
“It’s critical patients and doctors have access to results to ascertain benefits and harms,” said study author Alejandro Rivero-de-Aguilar.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet-
How many? One-third of late-stage trials testing multiple sclerosis drugs were never published.. https://t.co/dCbbmw45AG #pharma #MultipleSclerosis #clinicaltrials #transparency
-
How many? One-third of late-stage trials testing multiple sclerosis drugs were never published https://t.co/oFvdNblxDE via @statnews
-
Was Amgen less than forthcoming about FDA’s concerns on its cancer drug?.. my latest column.. feedback, suggestions, criticism are welcome.. https://t.co/2jo64dYAzZ #pharma #biotech #cancer #FDA #transparency #clinicaltrials $AMGN